Platinum chemotherapy’s long-term effects, surprising heart failure drug failures, and more biotech news from The Readout Gerry Broome/AP Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today: Cancer centers are grappling with persistent drug shortages, drug reps remain surprisingly entrenched in medical practice, and researchers find that platinum chemotherapy can leave lasting genetic scars in children. It’s the 25th anniversary of 9/11. Surreal and solemn feelings come to mind. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe Meghana Keshavan covers biotech and contributes to The Readout newsletter.
STAT+: Cancer drug shortages keep disrupting patient care
Full Article
Original Source
Read the full article at Statnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.